Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SHROOM3 antisense RNA 1 (SHROOM3-AS1) is a long non-coding RNA (lncRNA) transcript encoded at the SHROOM3 locus, identified by non-protein-coding gene databases. Its sequence and transcription are documented, but its cellular function, physiological role, and disease associations are not well characterized. It is not considered a therapeutic target in current biomedical literature, and no drugs or biomarkers have been linked to this molecule. Additional Notes: This entry refers to the antisense RNA (SHROOM3-AS1), not the protein SHROOM3, which is involved in cytoskeletal control during development, neural tube closure, and kidney function. Occasional confusion may arise due to similar names; ensure not to conflate SHROOM3-AS1 (RNA) with SHROOM3 (protein). If structured data is needed for disease roles, mechanisms, or drugs, refer to SHROOM3 protein and not SHROOM3-AS1.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SHROOM3 antisense RNA 1 (SHROOM3-AS1).